Research on China Heparin Industry, 2015

Publisher Name :
Date: 26-Aug-2015
No. of pages: 92

Currently there are 4 major products in the global low molecular heparin preparation market: SNY’s enoxaparin sodium, Pfizer’s dalteparin sodium, GSK’s nadroparin calcium and LEO’s tinzaparin sodium. Among which, enoxaparin remains the best –selling product even though its sales amount continued to decline in recent years.

Though enoxaparin always dominates the international heparin preparation market, low molecular heparin calcium is more competitive in China. Low molecular heparin calcium ranked the first position in the usage among sample hospitals in 2014, and has achieved a CAGR of 23% in the past 8 years. Moreover, enoxaparin, heparin sodium and low molecular heparin sodium ranked from 2nd to 4th respectively. These 4 products accounts for 63.6% in Chinese anticoagulant market in 2014.

There are 7 major players in Chinese low molecular heparin calcium market, 6 of them are domestic enterprises. Enoxaparin sodium was imported from SNY in 2003 and in 2006 the generic drug produced by Jiuyuan Gene Engineering Co., Ltd came into market. Currently there are 4 domestic enterprises with volume production. The sales amount of enoxaparin in city public hospitals reached RMB 153 million in 2014.

In 2014, GSK, Changshan Biochemical Pharmaceutical and Hefei Zhaoke were top3 enterprises in the domestic low molecular heparin calcium market, with total market share of 88.7% in 2014. GSK is the leading enterprises in this segment for a long time, but its growth has slowed down in recent 2 to 3 years. Changshan’s product achieved rapid development relying on independent pricing, which is gradually becoming the import substitution product.

In May 2015, Qianhong Bio-Pharma received the approval letter of enoxaparin sodium API and injection from CFDA. This made Qianhong the 5th enterprises for producing enoxaparin sodium in domestic market. (Time to volume production is still uncertain).

In July 2015, Dongcheng became the third enterprise that get approval of nadroparin, the other two are GSK (RLD) and Nanjing King-Friend (in April 2015). This is the company’s first low molecular heparin preparation product.

Research on China Heparin Industry, 2015

Table of Contents

1. Executive Summary
1.1 Definition & Classification
1.2 Industry Chain

2. Global Heparin Market
2.1 Supply & Demand
2.3 Market Competition
2.4  Market Forecast

3. Development of Heparin API Industry in China
3.1 Development Environment of Heparin Industry in China
3.1.1 Related Policies
3.1.2 Technical Requirements
3.1.3 Capital Barrier
3.2 Market Status
3.3 Market Supply & Demand
3.4 Competition Pattern
3.5 Import & Export
3.5.1 Export
3.5.2 Import
3.6 Development Prospect and Forecast

4. Development of Heparin Preparation Industry in China
4.1 Market Size
4.2  Low Molecular Heparin Preparation
4.2.1 Low Molecular Heparin Calcium Preparation
4.2.2 Low Molecular Heparin Sodium Preparation
4.3 Unfractionated Heparin Preparation
4.4 Development Prospect and Forecast

5. Key Heparin Enterprises in China
5.1 Hepalink
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Clients and Suppliers
5.1.7 Heparin Business
5.2 Qianhong Bio-Pharma
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Clients and Supplies
5.2.7 Heparin Business
5.2.8 Prospective
5.3 Dongcheng Biochemicals
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R& D and Investment
5.3.6 Clients
5.3.7 Heparin Business
5.3.8  Prospective
5.4 Changshan Biochemical Pharmaceutical
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R& D and Investment
5.4.6 Clients and Suppliers
5.4.7 Prospective
5.5 Tianjin Chase Sun
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R& D and Investment
5.5.6 Clients and Suppliers
5.5.7 Heparin Business
5.5.8 Prospective
5.6 Nanjing King-Friend
5.6.1 Profile
5.6.2 Operation and Prospective
5.7 Jiangsu Wanbang
5.7.1 Wanbang Biopharmaceuticals
5.7.2 Operation and Prospective
5.8 Hefei Zhaoke
5.8.1 Profile
5.8.2 Opearation
5.8.3 Heparin Business
5.9 Sciprogen
5.9.1 Profile
5.9.2 Opearation
5.9.3 Heparin Business
5.10 Hainan Unipul Pharmaceutical Co., Ltd.
5.10.1 Profile
5.10.2 Opearation
5.10.3 Heparin Business
5.11 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
5.11.1 Profile
5.10.2 Opearation
5.11.3 Heparin Business
5.11 Techpool
5.11.1 Profile
5.10.2 Opearation
5.11.3 Heparin Business

6. Industry Main Indicator

List of Charts

Application of Heparin Preparations
Heparin Industry Chain
Market Size of Heparin Preparation Worldwide and YoY Growth, 2006-2014
Performance Comparison Between Low Molecular Weight Heparin Preparation and Unfractionated Heparin Preparation
Market Size of Global Heparin Preparations by Product, 2010-2014
Regional Distribution of Heparin Preparations Worldwide, 2014
Global Heparin API Demand and YoY Growth, 2007-2014
Major Heparin Preparation Producers Worldwide
Sales of Major Heparin Preparation Brands Globally, 2010-2014
Global Market Size of Heparin Preparations, 2012-2016
Global Demand for Heparin API, 2011-2016
Gross Margin of Major Heparin API Producers in China, 2008-2015
Pig Slaughtering Volume and Breeding Stock in China, 2008-2014
Capacity of Heparin Crude Products in China, 2008-2014
Export Average Price of Heparin and Salt in China, 2008-2014
Capacity, Sales Volume and Certification of Major Heparin API Enterprises in China, 2014
Export Volume and Export Value of Heparin and Its Salts in China, 2008-2015
Export Price of Heparin and Its Salts in China, 2008-2015
Top 10 Export Destinations of China’s Heparin and Its Salts by Export Value, 2012-2015
Top 10 Export Enterprises of Heparin and Its Salts in China by Export Value, 2014
Import Volume, Import Value and Unit Price of Heparin and Its Salts in China, 2008-2015
Heparin Sodium API Projects Proposed/Under Construction in China as of Jun. 2014-2015
Market Size of Heparin Preparations in China and YoY Growth, 2007-2014
Market Share of Heparin Preparations in China by Product, 2014
Market Size of Low Molecular Weight Heparin Preparation in China, 2009-2014
Major Low Molecular Heparin Calcium Preparation Enterprises in China and Their Bidding Prices, 2014
Distribution of Low Molecular Heparin Calcium Market in China by Enterprises
Major Low Molecular Heparin Sodium Preparation Enterprises in China and Their Bidding Prices, 2014
Major Heparin Sodium Preparation Enterprises in China and Their Selling Prices, 2008-2014
Market Size of Heparin Preparation in China and YoY Growth, 2012-2016

  • Global Deep Vein Thrombosis (DVT) Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 20-Sep-2022        Price: US 5600 Onwards        Pages: 98
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Deep Vein Thrombosis (DVT) Drug companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, in......
  • Global Hemophilia Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 15-Sep-2022        Price: US 5600 Onwards        Pages: 100
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hemophilia Treatment companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry expe......
  • Global Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 12-Sep-2022        Price: US 5900 Onwards        Pages: 108
    Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various......
  • Global Injectable Anticoagulants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 12-Sep-2022        Price: US 5900 Onwards        Pages: 102
    The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Injectable Anticoagulants market is p......
  • Global Thrombin (Human) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 12-Sep-2022        Price: US 5600 Onwards        Pages: 115
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Thrombin (Human) manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry pub......
  • Global Deep Vein Thrombosis (DVT) Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 08-Sep-2022        Price: US 3450 Onwards        Pages: 100
    The report focuses on the Deep Vein Thrombosis (DVT) Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream m......
  • (Post-pandemic Era) - Global Injectable Anticoagulants Market Segment Research Report 2022
    Published: 07-Sep-2022        Price: US 3300 Onwards        Pages: 84
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain distur......
  • Post-pandemic Era - Global Injectable Anticoagulants Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
    Published: 07-Sep-2022        Price: US 4850 Onwards        Pages: 89
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain distur......
  • Global Heparin Sodium Market Research Report 2022
    Published: 06-Sep-2022        Price: US 2900 Onwards        Pages: 103
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral Type - Injection Type Segment by Application - Treatment of Venous Thromboembolism......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs